search returned 100 results for adalimumab, showing results 21 to 30
AUSTRALIAN PAEDIATRIC
RHEUMATOLOGY GROUP
2024/2025 Achievements
Policy:
- APRG ToR amended, and additional Executive Member (Chair Elect) introduced
Advocacy:
- The formation of the APRG Therapeutics Working Group to improve access to therapeutics
- Input to PBAC on adalimumab for juvenile
https://rheumatology.org.au/LinkClick.aspx?fileticket=ttEIsl5Cnmo%3d
AUSTRALIAN PAEDIATRIC
RHEUMATOLOGY GROUP
2024/2025 Achievements
Policy:
- APRG ToR amended, and additional Executive Member (Chair Elect) introduced
Advocacy:
- The formation of the APRG Therapeutics Working Group to improve access to therapeutics
- Input to PBAC on adalimumab for juvenile
https://rheumatology.org.au/LinkClick.aspx?fileticket=ttEIsl5Cnmo%3d&portalid=2
of adalimumab for juvenile ankylosing spondylitis.
For the purposes of this letter, we will refer... other forms of JIA (4).
There is high quality evidence showing that adalimumab is a safe..., such as adalimumab, are recommended for children and young
people with active sacroiliitis disease
https://rheumatology.org.au/LinkClick.aspx?fileticket=kPeTocMYiGA%3d
of adalimumab for juvenile ankylosing spondylitis.
For the purposes of this letter, we will refer... other forms of JIA (4).
There is high quality evidence showing that adalimumab is a safe..., such as adalimumab, are recommended for children and young
people with active sacroiliitis disease
https://rheumatology.org.au/LinkClick.aspx?fileticket=kPeTocMYiGA%3d&portalid=2
,
We thank you for the opportunity to advise on the current use of adalimumab for juvenile... such as adalimumab have been accessible through the Pharmaceutical Benefits
Scheme (PBS) for many..., particularly adalimumab, has drastically reduced since the
last review of the PBS JIA criteria
https://rheumatology.org.au/LinkClick.aspx?fileticket=W3EJpp%2fhD2M%3d
,
We thank you for the opportunity to advise on the current use of adalimumab for juvenile... such as adalimumab have been accessible through the Pharmaceutical Benefits
Scheme (PBS) for many..., particularly adalimumab, has drastically reduced since the
last review of the PBS JIA criteria
https://rheumatology.org.au/LinkClick.aspx?fileticket=W3EJpp_hD2M%3d&portalid=2
of adalimumab at the pharmacy level
Thank you for your letter dated 20 September 2021, in which...-subsidised Humira brand of adalimumab.
The Pharmacy Guild of Australia (Guild
https://rheumatology.org.au/LinkClick.aspx?fileticket=2HjLNLkdGsA%3d
of adalimumab at the pharmacy level
Thank you for your letter dated 20 September 2021, in which...-subsidised Humira brand of adalimumab.
The Pharmacy Guild of Australia (Guild
https://rheumatology.org.au/LinkClick.aspx?fileticket=2HjLNLkdGsA%3d&portalid=2
Brand Item SL Code Qty Rpts
adalimumab 40mg/0.8mLsyringe 9033K 9034L 12438P (PFS)
adalimumab 40mg/0.8mL pen 9101B 9102C 12415K (PFP)
adalimumab 40mg/0.4mL syringe (citrate free) 12378L 12398M 13216N (PFS)
adalimumab 40mg/0.4mL pen (citrate free) 12362P 12375H 13214L (PFP)
Item Qty Rpts Item Qty Rpts
https://rheumatology.org.au/LinkClick.aspx?fileticket=5IVB9VfWkyk%3d
Brand Item SL Code Qty Rpts
adalimumab 40mg/0.8mLsyringe 9033K 9034L 12438P (PFS)
adalimumab 40mg/0.8mL pen 9101B 9102C 12415K (PFP)
adalimumab 40mg/0.4mL syringe (citrate free) 12378L 12398M 13216N (PFS)
adalimumab 40mg/0.4mL pen (citrate free) 12362P 12375H 13214L (PFP)
Item Qty Rpts Item Qty Rpts
https://rheumatology.org.au/LinkClick.aspx?fileticket=5IVB9VfWkyk%3d&portalid=2